@DoRonRon. Wishful BS from SYA shareholders that don't like the idea they are only making a few hundred dollars per ton on the off-take agreement with a $900 ceiling. The following summary was released by Piedmont on 29 June 2022. There has been no subsequent release that advises the agreement of different terms, although it is obviously possible for PLL and SYA to mutually agree an amendment to the contract at any time.
Note1 - The term is Life-of-mine
Note2 - With joint agreement there is preferential supply to a jointly-owned lithium chemical plant. In this scenario the off-take still exists and Piedmont is still getting any residual spod produced beyond this requirement (up to 113kt or 50% but presumably it would be well under 113kt). This would create the possibly odd scenario of no Spod being sold to third parties at presumably rates above $900/t. Part of reaching joint agreement on a chemical plant may involve an amendment to these off-take terms, but it is pure HC speculation what any such changes may be.
- Forums
- ASX - By Stock
- PLL
- PLL General Discussion
PLL General Discussion, page-830
-
-
- There are more pages in this discussion • 1,845 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLL (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.5¢ |
Change
0.005(2.78%) |
Mkt cap ! $74.58M |
Open | High | Low | Value | Volume |
18.5¢ | 18.5¢ | 18.0¢ | $84.55K | 457.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3181 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 159776 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3181 | 0.185 |
10 | 380539 | 0.180 |
11 | 388962 | 0.175 |
8 | 786823 | 0.170 |
9 | 428069 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 159776 | 7 |
0.195 | 184405 | 4 |
0.200 | 311103 | 8 |
0.205 | 345128 | 6 |
0.210 | 1046947 | 16 |
Last trade - 13.07pm 12/11/2024 (20 minute delay) ? |
Featured News
PLL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online